Assignee
MANZANITA PHARMACEUTICALS INC
US·3 granted patents·2 pending applications·28 citations·filing 2003–2021
Top patents by PatentIndex Score
5 records- 0189US7718605B2Compounds for intracellular delivery of therapeutic moieties to nerve cellsMANZANITA PHARMACEUTICALS INC·Filed 2008·Granted May 18, 2010·14 cites·20 claims
- 0282US7678378B2Compounds for intracellular delivery of therapeutic moieties to nerve cellsMANZANITA PHARMACEUTICALS INC·Filed 2003·Granted Mar 16, 2010·14 cites·15 claims
- 0351US2024293562A1Methods for using neurotrophin receptor binding conjugate compositions in the treatment of a neurological conditionMANZANITA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0449US11897928B2Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereofMANZANITA PHARMACEUTICALS INC·Filed 2019·Granted Feb 13, 2024·0 cites·10 claims
- 0548US2022378949A1Neurotrophin receptor binding conjugate compositions, methods of use and methods of making thereofMANZANITA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MANZANITA PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →